# Batch Risk of Bias Eval Report

This report contains an audit trace: explicit extracted evidence, model-provided rationales, and label comparisons. It does not include hidden chain-of-thought.

- Studies: 5
- Domains: 25
- Accuracy: 15/25 (60.0%)

## Summary

| PMID | Study | Correct | Accuracy | Seconds |
|---|---|---:|---:|---:|
| 19487623 | King 2009 | 3/5 | 60.0% | 43.31 |
| 20579848 | Palacios 2009 | 3/5 | 60.0% | 34.53 |
| 21775755 | Ziegler 2011 | 2/5 | 40.0% | 45.56 |
| 22928960 | Houry 2012 | 4/5 | 80.0% | 39.01 |
| 23148458 | Sheridan 2012 | 3/5 | 60.0% | 32.08 |

## Error Types

- under-called_due_to_missing_or_underused_evidence: 7
- over-inferred_from_sparse_reporting: 2
- blinding_outcome_type_or_role_confusion: 1

## 19487623 - King 2009

- Mode: strict
- Article chars: 24566
- Extraction context chars: 12006
- Total seconds: 43.31

### Methodology Extraction

- `randomization_method`: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).
- `allocation_concealment_method`: Not reported
- `blinding_participants`: Not explicitly stated that participants were blinded; placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications.
- `blinding_personnel`: Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated.
- `blinding_outcome_assessors`: Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial. The evaluating clinician monitored efficacy and was blinded to adverse events.
- `attrition_details`: 149 were randomized to receive citalopram (n=73) or placebo (n=76). Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.
- `study_design`: Randomized, double-blind, placebo-controlled parallel-group trial (RCT).
- `additional_notes`: Liquid citalopram (Celexa, 10 mg/5 mL) was obtained commercially. Placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications. All efficacy and safety analyses used the intent-to-treat principle. Compliance was assessed by diary and by medication returned. The trial was registered (NCT00086645) and conducted at 6 academic medical centers; institutional review boards approved the study and a Data and Safety Management Board monitored the...

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Allocation concealment | Unclear risk | Unclear risk | yes |  |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: The methods explicitly state a random sequence generation method (permuted blocks with randomly varying block sizes stratified by site and age), which meets Cochrane criteria for low risk of bias in sequence generation.
- Model support: Quote: "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)." Comment: This describes a random component (permuted-block randomization with randomly varying block sizes), so sequence generation was probably done appropriately.
- GT support: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: Because the paper describes the randomization scheme but provides no details on procedures to prevent those enrolling participants from foreseeing assignments, there is insufficient information to determine whether allocation was adequately concealed; therefore risk of selection bias is unclear.
- Model support: Comment: Allocation concealment method not reported. Randomization used permuted blocks with varying block sizes stratified by site and age, but no information is given about how allocations were concealed (e.g. central randomization, sealed opaque envelopes, or pharmacy-controlled dispensing). Placebo was prepared at each site's pharmacy, suggesting local handling, but this does not confirm concealment procedures.
- GT support: Details not provided
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial is described as double-blind with a matched placebo and masked clinicians performing evaluations, indicating adequate blinding of participants and personnel; there is no indication that blinding was likely to be broken or that outcomes would be influenced by lack of blinding.
- Model support: Quote: "Randomized, double-blind, placebo-controlled parallel-group trial (RCT)." Comment: Placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy; two masked clinicians met with participants (one evaluating clinician blinded to adverse events). Probably done: blinding of participants and key study personnel was implemented and appears unlikely to have been broken.
- GT support: Two masked clinicians met with participants during each scheduled evaluation
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study explicitly states it was double-blind, with evaluating clinicians trained and blinded while using objective standardized rating scales; placebo was matched to active drug, making unblinding unlikely and measurement unlikely to be biased.
- Model support: Quote: "Randomized, double-blind, placebo-controlled parallel-group trial (RCT)." Comment: Evaluating clinicians were trained and "were blinded" (blinded to adverse events) and evaluated efficacy using standardized scales (CYBOCS-PDD, CGI). Placebo was matched for smell, taste, and viscosity. Probably done: outcome assessment was blinded and unlikely to have been broken.
- GT support: The evaluating clinician monitored efficacy and was blinded to AEs
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Missing outcome data were moderate (≈17.4% overall), similar in number and reasons across groups, and the study used ITT with last observation carried forward, so the risk that attrition introduced material bias is low.
- Model support: Quote: "149 were randomized to receive citalopram (n=73) or placebo (n=76). Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward." Comment: Attrition was relatively low and balanced across groups with similar reasons; analyses used intent-to-treat with LOCF imputation. Probably done: balanced reporting and reasonable handling of missing data.
- GT support: LTFU citalopram: 13 withdrew, 1 due to serious AE; 8 AEs; 2 protocol violations; 2 consent withdrawn LTFU placebo: 13 withdrawn, 7 AEs; 1 protocol violation; 5 consent withdrawn
- Source context preview: 


## 20579848 - Palacios 2009

- Mode: strict
- Article chars: 25127
- Extraction context chars: 12003
- Total seconds: 34.53

### Methodology Extraction

- `randomization_method`: Not reported
- `allocation_concealment_method`: Not reported
- `blinding_participants`: We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk to test the effects of calcium supplementation and dairy intake on body fat and serum lipids in obese Puerto Ricans.
- `blinding_personnel`: CRC-trained personnel, who were blinded to the study treatments, performed body weight and other measurements. (Quote: "Measurements were taken ... by the CRC-trained personnel, who were blinded to the study treatments.")
- `blinding_outcome_assessors`: Outcome assessors for body composition and weight: "Measurements were taken ... by the CRC-trained personnel, who were blinded to the study treatments." Other outcome assessor blinding not reported.
- `attrition_details`: Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. Of the 25 subjects who completed the study, 20 were female and 5 were male. Handling of missing data/analyses...
- `study_design`: Individual randomized controlled trial (single-center), parallel groups; three-arm randomized, placebo-controlled trial.
- `additional_notes`: Interventions: high dairy group (four daily servings of low-fat dairy, products provided monthly), high elemental calcium group (600 mg/d calcium carbonate supplement), control group (placebo tablet). Subjects were instructed to maintain usual energy intake and physical activity. Compliance monitored via monthly calendar, food records, FFQ, and 24-h recalls. Ethics approval and written consent reported.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk / Not applicable | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk / Not applicable | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Not applicable / Unclear risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: There is insufficient information about how the allocation sequence was generated; no random method (e.g. computer, random number table) is described, nor is any non-random method reported, so risk of bias for sequence generation cannot be determined.
- Model support: Comment: The report states only that this was a "randomized, double-blind ... placebo-controlled trial" but provides no description of the method used to generate the random sequence (randomization_method: "Not reported").
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated"
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The report does not specify how allocations were concealed prior to assignment, so there is insufficient information to determine whether investigators could foresee assignments; therefore risk of selection bias due to allocation concealment is unclear.
- Model support: Comment: Allocation concealment method not reported in the article excerpts or extracted methodology. No description of central randomization, sealed envelopes, or other concealment procedures is provided.
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated and the allocation concealment was performed centrally"
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk / Not applicable
- Match: True
- Model rationale: The trial explicitly states double-blind design and confirms that personnel taking key outcome measurements were blinded. Although the dairy intervention could not be fully blinded to participants, the outcomes were measured by blinded staff and are objective (weight, body composition, serum lipids), so lack of participant blinding is unlikely to have materially influenced these outcomes.
- Model support: Quote: "We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk to test the effects of calcium supplementation and dairy intake on body fat and serum lipids in obese Puerto Ricans." Comment: Study reports double-blind overall with single-blinding for the dairy group; CRC-trained personnel who performed weight and body composition measurements were blinded to study treatments (measurements quote in extracted data). Blinding of participants and key personnel was implemented where feasible and outcome assessment for main objective outcomes (body weight, body composition, serum lipids) was performed by blinded staff. Probably done.
- GT support: Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric...
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk / Not applicable
- Match: True
- Model rationale: Blinding of outcome assessment for the main outcomes (weight and body composition) was explicitly reported and is unlikely to have been broken, so detection bias for these outcomes is low. No evidence that lack of blinding affected outcome measurement.
- Model support: Quote: "Measurements were taken ... by the CRC-trained personnel, who were blinded to the study treatments." Comment: Outcome assessors for body composition and weight were explicitly stated to be blinded to study treatments. Other outcome assessor blinding not reported, but key objective outcomes (body weight, body composition) were measured by blinded personnel — Probably done.
- GT support: Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study." | Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr. Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study."
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Not applicable / Unclear risk
- Match: True
- Model rationale: While attrition was moderate (5/30, 17%), reasons are partially given but there is no information on whether missingness was related to outcomes, whether missing data were balanced across arms, or how missing data were handled in analyses; this insufficient reporting prevents judging the risk of bias from incomplete outcome data.
- Model support: Comment: Of 30 enrolled, 5 subjects dropped out before the second visit (reasons: one medical, four lost interest); 25 completed the study. Handling of missing data/analyses approach for dropouts not reported.
- GT support: 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who completed the study, 20 were female and 5 were male. Within the ﬁve males, one was allocated to the high dairy group, two to the high calcium group, and two to the control group." Comment: attrition rates were 10% and 20% but relating to a small number of randomised participants (N = 10) in both groups | 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who...
- Source context preview: 


## 21775755 - Ziegler 2011

- Mode: strict
- Article chars: 24371
- Extraction context chars: 12003
- Total seconds: 45.56

### Methodology Extraction

- `randomization_method`: Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six.
- `allocation_concealment_method`: Insufficient information. (Article states: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.")
- `blinding_participants`: "randomized, double-blind, placebo-controlled... using film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance"
- `blinding_personnel`: "randomized, double-blind, placebo-controlled..." "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency."
- `blinding_outcome_assessors`: "Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel (by P.A.L., W.J.L., P.J.D., and colleagues). All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners)." (No explicit statement that outcome assessors were blinded.)
- `attrition_details`: Not reported. (No numbers reported for losses to follow-up, withdrawals, or how missing data were handled in the provided text.)
- `study_design`: "multicenter (36 centers ...), randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial"
- `additional_notes`: Randomization used a randomization list generated by sponsor biostatistics and balanced with block size of six (undisclosed). Emergency unblinding possible via sealed envelopes held by investigators and monitor. Matching placebo tablets were identical in appearance. An interim analysis was performed with stopping rule P < 0.005; final alpha adjusted to 0.0452 per Šidák. Eligibility and outcome testing were performed by trained and certified personnel and evaluated by centralized Reading and...

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Incomplete outcome data: All outcomes | Unclear risk | High risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study explicitly states a randomization list was generated by the sponsor's Biostatistics Department and used block randomization, which indicates a random component in sequence generation and meets the criteria for low risk of bias for random sequence generation.
- Model support: Quote: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six." Comment: This describes a centrally generated randomization list (computer/statistical department) with block randomization; random sequence generation was likely done properly. Probably done.
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug ..."
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The report states a sponsor-generated randomization list with blocked allocation and mentions sealed envelopes for emergency decoding, but provides no clear description that allocation was concealed from those enrolling participants (e.g. central randomization or sequentially numbered, opaque, sealed envelopes). Therefore there is insufficient information to judge risk of selection bias from allocation concealment.
- Model support: Quote: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency." Comment: The article does not describe how allocation was concealed prior to assignment (e.g. central randomization or use of sequentially numbered, opaque, sealed envelopes). The only detail about envelopes refers to emergency unblinding, not the allocation process. Probably not enough information to determine whether adequate allocation concealment procedures were used.
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug, at distance of the centers the study took place"; "the random allocation was balanced using an undisclosed block size of six."
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial is explicitly described as randomized, double-blind, placebo-controlled with matching placebo tablets identical in appearance, indicating effective blinding of participants and personnel; the availability of sealed emergency envelopes does not imply routine unblinding or likely bias.
- Model support: Quote: "randomized, double-blind, placebo-controlled... using film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance"; "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency." Comment: Blinding of participants and personnel was implemented with matching placebo tablets and described as double-blind; emergency unblinding was possible but controlled. Probably done.
- GT support: Quote: "... matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance." Comment: trial described as double-blind.
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Although the trial is described as double-blind and employed matching placebo and procedures for emergency unblinding, the paper does not explicitly state that outcome assessors were blinded; given the subjective components of some outcomes (symptom scores, clinical scales), lack of explicit information prevents a clear judgment of low risk, so risk of detection bias is unclear.
- Model support: Comment: The report states the trial was "randomized, double-blind, placebo-controlled" and that assessments (NIS, NSC, nerve conduction, QSTs, autonomic tests) were performed by "trained and certified" personnel and centrally evaluated by Reading and Quality Assurance Centers. There is no explicit statement that outcome assessors were blinded, though matching placebo and emergency sealed envelopes for unblinding were used. Probably done but not clearly reported.
- GT support: Quote: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency."
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: High risk
- Match: False
- Model rationale: There is insufficient reporting of attrition and handling of missing outcome data to judge whether missingness could bias results, so risk of bias for incomplete outcome data is unclear.
- Model support: Comment: No information reported on numbers lost to follow-up, withdrawals, reasons for missing data, or how missing data were handled in the provided text; attrition details not reported.
- GT support: More than 40% of participants discontinued intervention in both groups during the 4-year study. We do not know how many participants were lost before the outcomes at 2 years (our outcome of interest), and how many after the first 2 years. Most participants (454/460) were included in the ITT analysis, but the study authors did not report for how many they managed to measure the outcome, and for how many they used the last observation carried forward ("mean of weeks 191 and 192 or last available value after randomization"). Apparently, the proportion of dropouts and the causes of dropout were equally distributed among the 2 groups.
- Source context preview: 


## 22928960 - Houry 2012

- Mode: strict
- Article chars: 20317
- Extraction context chars: 12006
- Total seconds: 39.01

### Methodology Extraction

- `randomization_method`: We used computer-generated randomization to assign new reviewers to either the intervention or control group.
- `allocation_concealment_method`: Not reported
- `blinding_participants`: All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors.
- `blinding_personnel`: Editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.
- `blinding_outcome_assessors`: Outcome measures were "review quality rating score for each reviewer" and "editor-assigned reviewer quality ratings" recorded contemporaneously within our editorial management software. (There is no explicit statement that outcome assessors were blinded.)
- `attrition_details`: Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees). During the study period the participants were...
- `study_design`: Randomized controlled trial (individual randomization of new reviewers to mentorship or control over a four-year consecutive sample).
- `additional_notes`: Participants: consecutive individuals newly added to our reviewer ranks during the study period; there were no exclusion criteria. Mentors were senior journal reviewers (top 50 list). Intervention: mentors and mentees were paired to review the same manuscript and mentees were asked to discuss their review with their mentor by email or telephone; content and amount of communication were left to mentor and mentee. Primary outcome: slope in change in editor-assigned reviewer quality ratings over...

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Unclear risk | Unclear risk | yes |  |
| Blinding of outcome assessment: All outcomes | Unclear risk | Unclear risk | yes |  |
| Incomplete outcome data: All outcomes | Low risk | Low risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The investigators explicitly state that computer-generated randomization was used, which meets the Cochrane criteria for a random component in sequence generation and indicates low risk of bias from this domain.
- Model support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group." Comment: Probably done — a computer random number generator is a valid random component for sequence generation.
- GT support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group."
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Computer-generated randomization is reported but there is no information about measures to prevent foreknowledge of assignments; insufficient detail to judge whether allocations were concealed, so risk of selection bias cannot be determined.
- Model support: Comment: Allocation concealment method not reported. The methods state: "We used computer-generated randomization to assign new reviewers to either the intervention or control group." No further details on how the allocation sequence was concealed (e.g. central randomization, sealed opaque envelopes) are provided.
- GT support: Computer-generated randomization and only a senior editor was aware of who was to receive the intervention.
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: While routine peer review processes were blinded regarding author identities and editors invited reviewers without knowing group assignment, there is insufficient information to determine whether reviewers, mentors, editors, or outcome assessors were blinded to mentorship vs control; lack of explicit reporting means risk of performance bias cannot be judged confidently.
- Model support: Comment: The report states that "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors." It also states editors invited reviewers "without knowledge of which new reviewers were assigned to the mentorship or control groups." There is no explicit statement that participants (reviewers) or personnel (editors/mentors) were blinded to group allocation with respect to the intervention, nor that outcome assessors of the editor-assigned quality ratings were blinded. Probably not done: blinding of outcome assessors is not reported.
- GT support: Quote: "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups." Comment: personnel were blinded but unclear if participants were blinded.
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: Because the study does not report whether the editors who assigned quality ratings were blinded to allocation, and the outcomes are subjective editor-assigned ratings that could be influenced by knowledge of group, there is insufficient information to judge low or high risk of detection bias.
- Model support: Comment: The report states that outcome measures were "review quality rating score for each reviewer" and "editor-assigned reviewer quality ratings" recorded contemporaneously within our editorial management software. There is no explicit statement that the editor-assessors (who assigned reviewer quality ratings) were blinded to the reviewers' group (mentorship vs control). Probably not done.
- GT support: Quote: "All reviews at Annals are routinely rated by editors for quality on a previously reported 5-point scale that has demonstrated moderate reliability and is comparable to the scale validated by van Rooyen." Comment: unclear if the editors were aware of allocation when assessing the reviews.
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: Reasons for missing data are reported and appear unrelated to outcomes (non-contact with mentors), an ITT analysis was performed with similar results, and the amount/handling of missing data is unlikely to introduce clinically relevant bias, so risk is low.
- Model support: Quote: "Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees). During the study period the participants were invited to perform 912 reviews, and accepted and completed 490 reviews." Comment: The authors report the number and reasons for missing data, performed both per-protocol and intention-to-treat analyses and state the ITT gave essentially identical results (Probably done). Missing outcome data appear balanced and unlikely to bias results materially.
- GT support: Quote: "per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown)." Comment: 4 subjects in the intervention group did not receive the intervention and were excluded from the analysis. The researchers state that an ITT analysis "yielded essentially identical results" but the analyses are not included in the paper.
- Source context preview: 


## 23148458 - Sheridan 2012

- Mode: strict
- Article chars: 34179
- Extraction context chars: 12003
- Total seconds: 32.08

### Methodology Extraction

- `randomization_method`: Randomization used computer-generated random numbers that were sealed in opaque envelopes.
- `allocation_concealment_method`: Randomization used computer-generated random numbers that were sealed in opaque envelopes.
- `blinding_participants`: "Men in the highway safety group viewed the highway safety video, but received no accompanying coaching session." Also: "At the end of the coaching session, men were given a summary sheet of their opinions on prostate cancer screening to share with their physician." No explicit statement that participants were blinded to group assignment.
- `blinding_personnel`: Not reported
- `blinding_outcome_assessors`: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)" — physicians were notified only about participation, but not group assignment. No other information about outcome assessor blinding.
- `attrition_details`: Not reported
- `study_design`: Randomized controlled trials (two trials combined); individual-randomized within practices (not cluster).
- `additional_notes`: Participants were randomized within practices after providing informed consent and completing a baseline survey. Interventions and surveys were delivered prior to appointments in a private room. Data from two separate trials (prostate-only and men's health framing) were combined for analysis; implementation and measurement strategies were identical to allow combining if no differences were noted.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Low risk | Low risk | yes |  |
| Blinding of participants and personnel: All outcomes | High risk | Low risk | no | blinding_outcome_type_or_role_confusion |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The investigators used a computer random number generator to create the allocation sequence, which meets the Cochrane criteria for low risk of bias in sequence generation; the description is sufficiently specific to judge the process as random.
- Model support: Quote: "Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: The report explicitly states a random component (computer-generated random numbers) and describes sequence concealment (sealed opaque envelopes). Probably done.
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Source context preview: 

#### Allocation concealment

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study explicitly states that computer-generated allocations were sealed in opaque envelopes, indicating that those enrolling participants could not foresee assignments, meeting criteria for low risk of selection bias from inadequate concealment.
- Model support: Quote: "Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: This describes allocation concealment using sealed opaque envelopes, which is an accepted method. Probably done.
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: High risk
- Ground truth: Low risk
- Match: False
- Model rationale: The intervention involved active coaching and provision of a summary sheet, while controls viewed a different video; there is no evidence participants or personnel were blinded and outcomes were patient-reported decisions, which are likely susceptible to performance bias from lack of blinding.
- Model support: Comment: No explicit statement that participants were blinded; participants in the control (highway safety) group viewed a different video and the intervention included a coaching session and a summary sheet to share with their physician. Personnel blinding not reported; physicians were notified of participation but not group assignment. Given the nature of the intervention (video + coaching + summary sheet) participants and delivering personnel were almost certainly aware of group allocation and outcomes (patient-reported decision measures) could be influenced by that knowledge. Probably not done.
- GT support: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)." Although described as single‐masked in the study registration, due to the attention control intervention in the control groups, both participants and staff could be considered blinded.
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: Physicians (the likely outcome assessors) were explicitly not informed of participants' group assignments, and outcomes were patient-reported decision measures or objective, so lack of assessor knowledge is unlikely to bias outcome measurement.
- Model support: Quote: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)" Comment: Outcome assessors (physicians) were not informed of group assignment; no other outcome assessors are identified. Probably done — blinding of outcome assessment was in place for physician-reported outcomes and measurement is largely objective or patient-reported, unlikely to be influenced by lack of assessor blinding.
- GT support: Self‐reported outcome measures, therefore, low risk considering masking of participants.
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Insufficient reporting of attrition/exclusions prevents judgment about whether missing data were balanced or likely related to outcomes, so risk of bias due to incomplete outcome data is unclear.
- Model support: Comment: No information on attrition or incomplete outcome data was reported in the extracted methods; 'attrition_details' is listed as "Not reported."
- GT support: SeeFigure 1for reporting on missing data (only 2 participants in intervention group due to false inclusion)
- Source context preview: 

## Workflow Evolution Notes

- Inspect mismatches where prediction is `Unclear risk` but GT is `Low risk`: these usually mean retrieval or Stage 1 extraction missed a concrete methodological phrase.
- Inspect mismatches where prediction is `Low risk` or `High risk` but GT is `Unclear risk`: these usually mean the prompt is allowing too much inference from generic trial language.
- For blinding mismatches, add outcome-type cues to the prompt: self-report outcomes, objective outcomes, assessor-administered outcomes, and whether lack of blinding can materially affect the outcome.
- For allocation concealment mismatches, require the model to distinguish sequence generation from concealment before assignment.